TODAY'S HEADLINES

Diabetes complications fuel rising costs

Medication nonadherence and complications from type 2 diabetes is resulting in significant economic and societal burdens in the U.S. and other countries, according to a new report. Read more

FDA approves cannabis-derived drug

FDA approved dronabinol oral solution (Syndros), a liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol. Read more

CONTINUING PHARMACY EDUCATION

Expanding vaccination rates through pharmacist-initiated patient identification and assessment

This month's CE activity, "Expanding vaccination rates through pharmacist-initiated patient identification and assessment," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians about current vaccine recommendations so that they can identify adolescent and adult patients who may need vaccinations. Readers will also gain knowledge about where to obtain information about current vaccine recommendations.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

How FDA aims to support generic opioids

FDA recently outlined an action plan to reassess its approach to opioid medications. Read more

July 29, 2016

Related Articles

FDA approves rare liver disease drug

Oncologists not prescribing expensive cancer drugs